DCT
Basic information
Region (hg38): 13:94436811-94479682
Previous symbols: [ "TYRP2" ]
Links
Phenotypes
GenCC
Source:
- oculocutaneous albinism type 8 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Oculocutaneous albinism, type VIII | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Ophthalmologic | 33100333 |
ClinVar
This is a list of variants' phenotypes submitted to
- Oculocutaneous albinism type 8 (1 variants)
- Familial multiple polyposis syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 39 | 43 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 39 | 3 | 2 |
Highest pathogenic variant AF is 0.0000131
Variants in DCT
This is a list of pathogenic ClinVar variants found in the DCT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-94439905-T-C | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
13-94439918-T-C | Inborn genetic diseases | Uncertain significance (Jan 04, 2024) | ||
13-94439927-T-G | Inborn genetic diseases | Uncertain significance (Aug 12, 2021) | ||
13-94440051-C-T | Oculocutaneous albinism type 8 | Pathogenic (Sep 17, 2021) | ||
13-94440055-C-A | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
13-94443496-T-C | Uncertain significance (Nov 17, 2023) | |||
13-94443496-TAGTCACTGGAGGGA-T | Oculocutaneous albinism type 8 • Albinism | Pathogenic/Likely pathogenic (Apr 20, 2021) | ||
13-94443535-G-A | Inborn genetic diseases | Uncertain significance (Jul 06, 2021) | ||
13-94443541-G-C | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
13-94443547-T-C | Inborn genetic diseases | Uncertain significance (Feb 15, 2023) | ||
13-94443580-G-A | Inborn genetic diseases | Likely benign (Feb 05, 2024) | ||
13-94443596-C-T | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
13-94443759-T-C | Age related macular degeneration 7 | association (-) | ||
13-94445735-G-A | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) | ||
13-94445748-T-C | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
13-94460093-C-T | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
13-94460129-C-T | Inborn genetic diseases | Uncertain significance (Feb 06, 2023) | ||
13-94460138-C-A | Inborn genetic diseases | Uncertain significance (Aug 22, 2023) | ||
13-94460145-G-T | Inborn genetic diseases | Uncertain significance (Jun 14, 2023) | ||
13-94460162-T-G | Inborn genetic diseases | Uncertain significance (Dec 28, 2023) | ||
13-94460200-G-T | Inborn genetic diseases | Uncertain significance (Feb 10, 2023) | ||
13-94462026-A-C | Inborn genetic diseases | Uncertain significance (Mar 01, 2023) | ||
13-94462027-G-T | Inborn genetic diseases | Uncertain significance (Apr 09, 2024) | ||
13-94462139-C-T | Inborn genetic diseases | Uncertain significance (Jan 18, 2022) | ||
13-94462177-G-T | Oculocutaneous albinism type 8 | Pathogenic (Sep 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCT | protein_coding | protein_coding | ENST00000446125 | 10 | 42379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.39e-14 | 0.121 | 125586 | 0 | 162 | 125748 | 0.000644 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.348 | 326 | 309 | 1.06 | 0.0000170 | 3612 |
Missense in Polyphen | 143 | 127.56 | 1.121 | 1518 | ||
Synonymous | 0.672 | 109 | 118 | 0.921 | 0.00000682 | 1054 |
Loss of Function | 0.837 | 23 | 27.8 | 0.829 | 0.00000163 | 291 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00229 | 0.00229 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00180 | 0.00180 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000530 | 0.000528 |
Middle Eastern | 0.00180 | 0.00180 |
South Asian | 0.000629 | 0.000621 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of L-dopachrome into 5,6- dihydroxyindole-2-carboxylic acid (DHICA) (PubMed:8306979). Involved in regulating eumelanin and phaeomelanin levels. {ECO:0000269|PubMed:8306979}.;
- Pathway
- Tyrosine metabolism - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Tyrosinemia, transient, of the newborn;Dopamine beta-hydroxylase deficiency;Disulfiram Action Pathway;Tyrosine Metabolism;Alkaptonuria;Monoamine oxidase-a deficiency (MAO-A);Hawkinsinuria;Tyrosinemia Type I;Neural Crest Differentiation;Metabolism of amino acids and derivatives;Tyrosine metabolism;Metabolism;Melanin biosynthesis;eumelanin biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.551
Intolerance Scores
- loftool
- 0.114
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.14
Haploinsufficiency Scores
- pHI
- 0.340
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.886
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dct
- Phenotype
- vision/eye phenotype; pigmentation phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- positive regulation of neuroblast proliferation;melanin biosynthetic process from tyrosine;epidermis development;ventricular zone neuroblast division;melanin biosynthetic process;developmental pigmentation;cell development;oxidation-reduction process
- Cellular component
- cytosol;integral component of membrane;melanosome membrane;melanosome
- Molecular function
- dopachrome isomerase activity;copper ion binding;oxidoreductase activity